Matinas BioPharma (MTNB) Short Interest Ratio & Short Volume → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free MTNB Stock Alerts $0.17 0.00 (0.00%) (As of 05/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Matinas BioPharma Short Interest DataCurrent Short Volume3,190,000 sharesPrevious Short Volume3,270,000 sharesChange Vs. Previous Month-2.45%Dollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover2.1Last Record DateApril 15, 2024Outstanding Shares217,480,000 sharesPercentage of Shares Shorted1.47%Today's Trading Volume536,278 sharesAverage Trading Volume1,366,270 sharesToday's Volume Vs. Average39% Short Selling Matinas BioPharma ? Sign up to receive the latest short interest report for Matinas BioPharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMTNB Short Interest Over TimeMTNB Days to Cover Over TimeMTNB Percentage of Float Shorted Over Time Ad Manward PressShocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company Matinas BioPharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,190,000 shares $0.00 -2.5%N/A2.1 $0.00 3/31/20243,270,000 shares $0.00 +147.7%N/A2.2 $0.00 3/15/20241,320,000 shares $0.00 -10.2%N/A1 $0.00 2/29/20241,470,000 shares $0.00 +22.5%N/A1.5 $0.00 2/15/20241,200,000 shares $0.00 -15.5%N/A1.2 $0.00 1/31/20241,420,000 shares $0.00 +8.4%N/A1 $0.00 Get the Latest News and Ratings for MTNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Matinas BioPharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,310,000 shares $0.00 -36.4%N/A0.8 $0.00 12/31/20232,060,000 shares $0.00 -10.0%N/A0.2 $0.00 12/15/20232,290,000 shares $0.00 -34.4%N/A0.2 $0.00 11/30/20233,490,000 shares $0.00 -21.6%N/A0.4 $0.00 11/15/20234,450,000 shares $0.00 -2.8%N/A0.5 $0.00 10/31/20234,580,000 shares $0.00 -23.9%N/A0.5 $0.00 10/15/20236,020,000 shares $0.00 +3,030.5%N/A0.7 $0.00 9/30/2023192,300 shares $0.00 -31.0%N/A0.2 $0.00 9/15/2023278,500 shares $0.00 -60.9%N/A0.4 $0.00 8/31/2023711,500 shares $0.00 -38.1%N/A1.1 $0.00 8/15/20231,150,000 shares $0.00 -24.8%N/A1.7 $0.00 7/31/20231,530,000 shares $0.00 +11.7%N/A3.2 $0.00 7/15/20231,370,000 shares $0.00 -14.4%N/A2.8 $0.00 6/30/20231,600,000 shares $576,000.00 +4.6%N/A2.9 $0.36 6/15/20231,530,000 shares $0.00 +25.4%N/A3 $0.00 5/31/20231,220,000 shares $0.00 -12.9%N/A2.5 $0.00 5/15/20231,400,000 shares $0.00 -14.1%N/A3.2 $0.00 4/30/20231,630,000 shares $0.00 +48.2%N/A4.4 $0.00 4/15/20231,100,000 shares $0.00 -9.8%N/A3 $0.00 3/31/20231,220,000 shares $0.00 +8.9%N/A4.4 $0.00 3/15/20231,120,000 shares $0.00 -26.8%N/A3.6 $0.00 2/28/20231,530,000 shares $0.00 +10.1%N/A3.9 $0.00 2/15/20231,390,000 shares $0.00 -6.1%N/A3.5 $0.00 1/31/20231,480,000 shares $0.00 +5.0%N/A3.8 $0.00 1/15/20231,410,000 shares $0.00 -2.1%N/A3.2 $0.00 12/30/20221,440,000 shares $720,000.00 -23.4%N/A3.4 $0.50 12/15/20221,880,000 shares $0.00 +20.5%N/A4.7 $0.00 11/30/20221,560,000 shares $0.00 -2.5%N/A4.7 $0.00 11/15/20221,600,000 shares $0.00 -3.0%N/A5.8 $0.00 10/31/20221,650,000 shares $1.29 million +2.5%N/A5.4 $0.78 10/15/20221,610,000 shares $0.00 -6.4%N/A5.1 $0.00 9/30/20221,720,000 shares $0.00 +1.2%N/A5.8 $0.00 9/15/20221,700,000 shares $0.00 +6.3%N/A5 $0.00 8/31/20221,600,000 shares $1.14 million +1.9%N/A4.3 $0.71The Department of Defense Has a New Drone Contractor (Ad)The Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest MTNB Short Interest - Frequently Asked Questions What is Matinas BioPharma's current short interest? Short interest is the volume of Matinas BioPharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 3,190,000 shares of MTNB short. Learn More on Matinas BioPharma's current short interest. What is a good short interest ratio for Matinas BioPharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MTNB shares currently have a short interest ratio of 2.0. Learn More on Matinas BioPharma's short interest ratio. Is Matinas BioPharma's short interest increasing or decreasing? Matinas BioPharma saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 3,190,000 shares, a drop of 2.4% from the previous total of 3,270,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Matinas BioPharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Matinas BioPharma: Lexaria Bioscience Corp. (3.70%), Cara Therapeutics, Inc. (5.62%), Ocuphire Pharma, Inc. (6.17%), Unicycive Therapeutics, Inc. (1.53%), Immuneering Co. (13.23%), Bolt Biotherapeutics, Inc. (8.63%), Xilio Therapeutics, Inc. (4.35%), Apollomics, Inc. (0.32%), ProMIS Neurosciences, Inc. (0.16%), Rockwell Medical, Inc. (2.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Matinas BioPharma stock? Short selling MTNB is an investing strategy that aims to generate trading profit from Matinas BioPharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Matinas BioPharma? A short squeeze for Matinas BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MTNB, which in turn drives the price of the stock up even further. How often is Matinas BioPharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MTNB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: DURECT Short Interest JanOne Short Interest CASI Pharmaceuticals Short Interest ProMIS Neurosciences Short Interest Apollomics Short Interest Marker Therapeutics Short Interest BriaCell Therapeutics Short Interest IGC Pharma Short Interest Fortress Biotech Short Interest VYNE Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:MTNB) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow Investor[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyThe AI Stock that’s Disrupting Every IndustryStockEarnings